A DEA flag at the end of the funnel - means starting over
Without a manual regulatory review at the end of the cycle when pivoting is most expensive. FAVES screens every molecule against eight jurisdictions inline - at every compute stage, not as a separate step.
“Run compliance on this lead series before we proceed to docking.”
How it works
Submit a molecule with context
Provide the SMILES, intended use (pharmaceutical, research, industrial), and jurisdiction. FAVES V4 evaluates against DEA, FDA, EPA, CWC, EU REACH, Australia Schedule, BTWC, and OPCW.
Three-tier detection
Whitelist check → direct matching against schedule databases → scaffold analysis with 1,585 structural alert patterns. BOILED-Egg permeability. Prior art and disclosure screening.
PROCEED, CAUTION, or STOP
A clear verdict with jurisdiction-specific recommendations. Runs inline at every compute stage - lead optimization, docking, MD - not as a post-process.
Proof
FAVES V4: three-tier detection - whitelist → direct matching → scaffold analysis. 1,585 structural alert patterns.
100% sensitivity and specificity on 102-compound benchmark (51 controlled, 51 clean).
BOILED-Egg GI absorption and BBB permeability. Context-aware evaluation by intended use and jurisdiction.
Compliance at every junction
Eight jurisdictions. Inline. Sign up and screen your first molecule.